Saddle Point Science Europe develops advanced technologies that contribute to more accurate diagnoses for more effective treatments.
Personalized medicine
Personalized medicine offers the opportunity to tailor treatments specifically to the individual needs of patients, improving quality of life and making healthcare more efficient.
Biomedical data science startup Saddle Point Science Europe aims to develop new mathematical, statistical, and computational techniques to address the challenges of data analysis in modern medicine. This enables more precise predictions of treatments and reduces clinical risks. Predicting which patients are most likely to respond to a specific treatment has the potential to improve treatment outcomes, reduce costs, and minimize side effects for patients. Furthermore, data analysis methods involving limited patient data can promote the development of new therapies for rare diseases.
Saddle Point Science Europe B.V. is located in Nijmegen.
Founder: Ton Coolen Email: info@saddlepointscience.eu
Website: https://www.saddlepointscience.eu/
LinkedIn: https://www.linkedin.com/company/saddle-point-science-europe
